You have 9 free searches left this month | for more free features.

Pharmaceutical Solutions

Showing 3026 - 3050 of 3,362

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Erectile Dysfunction, Sigmoid Colon Cancer, Rectal Cancer Trial in Seongnam (Udenafil)

Completed
  • Erectile Dysfunction
  • +2 more
  • Seongnam, Korea, Republic of
    Department of Surgery, Seoul National University Bundang Hospita
Sep 2, 2012

Albumin, Total and Free Fraction of Mycophenolic Acid, and

Completed
  • Liver Transplant
    • Oslo, Norway
      Oslo university Hospital, Rikshospitalet
    Sep 13, 2012

    Contact Lens Wear Trial (OPTI-FREE RepleniSH multipurpose disinfecting solution, Clear Care contact lens care system, Contact

    Completed
    • Contact Lens Wear
    • OPTI-FREE RepleniSH multipurpose disinfecting solution
    • +2 more
    • (no location specified)
    Sep 13, 2012

    Osteonecrosis Trial in Australia (Zoledronic Acid, Placebo)

    Unknown status
    • Osteonecrosis
    • Zoledronic Acid
    • Placebo
    • Sydney, New South Wales, Australia
    • +4 more
    Jan 11, 2013

    Cataract Trial in Fort Worth (Nepafenac ophthalmic solution 0.1%, Ketorolac Tromethamine ophthalmic solution 0.4%, Nepafenac

    Completed
    • Cataract
    • Nepafenac ophthalmic solution 0.1%
    • +2 more
    • Fort Worth, Texas
      Contact Alcon for Trial Locations
    Mar 1, 2012

    Glaucoma, Ocular Hypertension Trial (Travoprost ophthalmic solution 0.004% with SofZia® preservative system (TRAVATAN Z®),

    Completed
    • Glaucoma
    • Ocular Hypertension
    • Travoprost ophthalmic solution 0.004% with SofZia® preservative system (TRAVATAN Z®)
    • Latanoprost ophthalmic solution 0.005% (XALATAN®)
    • (no location specified)
    Mar 30, 2012

    Contact Lens Wettability Trial in Fort Worth (FID 114675A multi-purpose disinfecting solution (MPDS), Soft contact lens, Blister

    Completed
    • Contact Lens Wettability
    • FID 114675A multi-purpose disinfecting solution (MPDS)
    • +2 more
    • Fort Worth, Texas
      Contact Alcon Call Center for Trial Locations
    Mar 21, 2012

    Squamous Cell Carcinoma Trial (API 31510 Topical Cream)

    Withdrawn
    • Squamous Cell Carcinoma
    • API 31510 Topical Cream
    • (no location specified)
    Jul 24, 2012

    ADHD, Attention Deficit Disorders With Hyperactivity, ADHDs Trial in United States (Vyvanse (lisdexamfetamine dimesylate),

    Completed
    • Attention Deficit Hyperactivity Disorder
    • +2 more
    • Vyvanse (lisdexamfetamine dimesylate), NRP104
    • Little Rock, Arkansas
    • +44 more
    Aug 16, 2012

    Skin Flora Contamination Trial in Worldwide (InteguSeal* skin sealant and standard surgical preparation, Standard preoperative

    Completed
    • Skin Flora Contamination
    • InteguSeal* skin sealant and standard surgical preparation
    • Standard preoperative skin preparation
    • Marietta, Georgia
    • +4 more
    Sep 13, 2012

    Urologic Surgical Procedures Trial in Cairo (6% HES 130/0.4 in NaCl 0.9% (Voluven, Fresenius Kabi, Bad Hom-bourg, Germany),

    Unknown status
    • Urologic Surgical Procedures
    • 6% HES 130/0.4 in NaCl 0.9% (Voluven, Fresenius Kabi, Bad Hom-bourg, Germany)
    • Tetraspan, B. Braun, Melsungen, Germany
    • Cairo, Egypt
      Kasralainy Hospital
    Aug 20, 2012

    Contact Lens Care Trial in Fort Worth (OptiFree Multi-Purpose Disinfecting Solution)

    Completed
    • Contact Lens Care
    • OptiFree Multi-Purpose Disinfecting Solution
    • Fort Worth, Texas
      Fort Worth Site
    Aug 15, 2012

    Contact Lens Moisture Trial in Fort Worth (FID 114675A Multi-Purpose Disinfecting Solution (MPDS), ReNu Fresh Lens Comfort

    Completed
    • Contact Lens Moisture
    • FID 114675A Multi-Purpose Disinfecting Solution (MPDS)
    • +2 more
    • Fort Worth, Texas
      Contact Alcon Call Center for Trial Locations
    Mar 21, 2012

    Glaucoma, Open-angle, Ocular Hypertension Trial in Puurs (Travoprost 0.004%/Timolol maleate 0.5% ophthalmic solution,

    Completed
    • Glaucoma, Open-angle
    • Ocular Hypertension
    • Travoprost 0.004%/Timolol maleate 0.5% ophthalmic solution
    • Latanoprost 0.005%/Timolol 0.005% ophthalmic solution
    • Puurs, Belgium
      European Facilitiies
    Feb 11, 2012

    Open-Angle Glaucoma, Ocular Hypertension Trial (Travoprost 0.004%/Timolol 0.5% Ophthalmic Solution, Latanoprost 0.005%

    Completed
    • Open-Angle Glaucoma
    • Ocular Hypertension
    • Travoprost 0.004%/Timolol 0.5% Ophthalmic Solution
    • +3 more
    • (no location specified)
    Feb 11, 2012

    Open-angle Glaucoma, Ocular Hypertension Trial (Travoprost 0.004% / Timolol 0.5% Ophthalmic Solution, Timolol Vehicle,

    Completed
    • Open-angle Glaucoma
    • Ocular Hypertension
    • Travoprost 0.004% / Timolol 0.5% Ophthalmic Solution
    • +3 more
    • (no location specified)
    Feb 13, 2012

    Acute Respiratory Distress Syndrome Trial (check biomarker :RAGE)

    Unknown status
    • Acute Respiratory Distress Syndrome
    • check biomarker :RAGE
    • (no location specified)
    Dec 26, 2012

    Open Angle Glaucoma, Ocular Hypertension Trial (Travoprost 0.004% (POLYQUAD-preserved) Eye Drops, Solution, Travoprost 0.004%

    Completed
    • Open Angle Glaucoma
    • Ocular Hypertension
    • Travoprost 0.004% (POLYQUAD-preserved) Eye Drops, Solution
    • Travoprost 0.004% (BAK-preserved) Eye Drops, Solution
    • (no location specified)
    Apr 4, 2012

    Open-angle Glaucoma, Ocular Hypertension Trial (AL-12182 0.003% Ophthalmic Solution, AL-12182 Ophthalmic Solution Vehicle,

    Completed
    • Open-angle Glaucoma
    • Ocular Hypertension
    • AL-12182 0.003% Ophthalmic Solution
    • +4 more
    • (no location specified)
    Feb 11, 2012

    Pulmonary Arterial Hypertension Trial in Minneapolis (Sodium Nitrite Inhalation Solution, Placebo and AIR001 Inhalation Solution

    Completed
    • Pulmonary Arterial Hypertension
    • Sodium Nitrite Inhalation Solution
    • Placebo and AIR001 Inhalation Solution (Expansion arm)
    • Minneapolis, Minnesota
      DaVita Clinical Research
    Feb 15, 2012

    Hypertonic Solutions in Severely Head-Injured Patients

    Terminated
    • Traumatic Brain Injury
    • Intracranial Hypertension
    • San Antonio, Texas
      Center for Neurosurgery Sciences - UTHSCSA - Surgical Intensive
    Jun 22, 2012

    Contact Lens Care Trial (FID 114675A Multi-Purpose Disinfecting Solution (MPDS), RepleniSH Multi-Purpose Disinfecting Solution

    Completed
    • Contact Lens Care
    • FID 114675A Multi-Purpose Disinfecting Solution (MPDS)
    • +3 more
    • (no location specified)
    Mar 21, 2012

    Migraine Headaches Trial in Chapel Hill (Craniosacral therapy, Low strength static magnets)

    Completed
    • Migraine Headaches
    • Craniosacral therapy
    • Low strength static magnets
    • Chapel Hill, North Carolina
      University of North Carolina at Chapel Hill
    Nov 30, 2012

    Rhinitis, Allergic, Seasonal, Conjunctivitis, Allergic Trial in Bangalore (olopatadine HCl /ketorolac tromethamine fixed dose

    Completed
    • Rhinitis, Allergic, Seasonal
    • Conjunctivitis, Allergic
    • olopatadine hydrochloride /ketorolac tromethamine fixed dose combination ophthalmic solution
    • olopatadine hydrochloride 0.1% ophthalmic solution
    • Bangalore, Karnataka, India
      (unnamed)
    Jan 24, 2012

    Lateral Epicondylitis Trial in Silkeborg (biological, procedure, drug)

    Completed
    • Lateral Epicondylitis
    • Platelet Rich Plasma
    • +2 more
    • Silkeborg, Denmark
      Silkeborg Regional Hospital Department of Reumatology
    Feb 13, 2012